Back
Zoetis Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
36
ZTS
Zoetis
Last Price:
175.14
Seasonality Move:
6.56%
Sell
48
BMRN
Biomarin Pharmaceutical
Last Price:
66.00
Seasonality Move:
14.81%
Sell
36
Zoetis (ZTS)
is a Sell
Is Zoetis a Buy, Sell or Hold?
- The current Zoetis [ZTS] share price is $181.95. The Score for ZTS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- ZTS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $66.60. The Score for BMRN is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- BMRN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ZTS Stock Price Chart
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $66.60
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.
ZTS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.55 | Sell |
| Relative Strength Index (14 RSI): | 41.13 | Sell |
| Chaikin Money Flow: | 1151628 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (183.51 - 193.53) | Sell |
| Bollinger Bands (100): | (176.19 - 190.85) | Sell |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.86 | Sell |
| Relative Strength Index (14 RSI): | 31.12 | Sell |
| Chaikin Money Flow: | 1072649 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (68.2 - 70.76) | Sell |
| Bollinger Bands (100): | (72.25 - 88.57) | Sell |
ZTS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 182.25 | Sell |
| 20-day SMA: | 187.25 | Sell |
| 50-day SMA: | 188.73 | Sell |
| 200-day SMA: | 179.38 | Buy |
| 8-day EMA: | 182.86 | Sell |
| 20-day EMA: | 186.09 | Sell |
| 50-day EMA: | 186.93 | Sell |
| 200-day EMA: | 181.29 | Buy |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.66 | Sell |
| 20-day SMA: | 69.42 | Sell |
| 50-day SMA: | 75.52 | Sell |
| 200-day SMA: | 82.98 | Sell |
| 8-day EMA: | 68.12 | Sell |
| 20-day EMA: | 69.64 | Sell |
| 50-day EMA: | 73.86 | Sell |
| 200-day EMA: | 81.73 | Sell |
Zoetis Earnings Growth & ZTS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $0.64 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.24 per share, and an increase next year of $0.79 per share.
Zoetis Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||